Shares of IPCA Laboratories traded higher by 6% in afternoon trade after the company reported stellar Q2 numbers.
Consolidated total Income went up 26% yoy at Rs1,298.70cr cr. Indian formulations income was up 16% yoy at Rs543.21cr.
Exports income went up 27% yoy at Rs588.03cr. Consolidated EBITDA margin came in at 22.69% in Q2FY20.
Consolidated Net Profit stood at Rs193.54cr up 63% yoy.
Stock View:
Ipca Laboratories Ltd is currently trading at Rs1,071.85 up by Rs61.45 or 6.08% from its previous closing of Rs1,010.40 on the BSE.
The scrip opened at Rs1,006.30 and has touched a high and low of Rs1,081.35 and Rs1,005.35 respectively. So far 3,07,501 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs12,766.62cr.
This Information is really good and informative. Thanks for it.
ReplyDeleteCheck below links and get useful information.
PSBs